Lyell Immunopharma Balance Sheet (2019-2026) | LYEL

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
564.44M393.50M293.83M222.60M205.74M116.31M123.55M109.43M224.37M286.21M145.65M125.65M133.42M100.30M105.60M120.33M98.80M123.58M60.18M90.77M
Prepaid Assets (Quarter)
10.32M12.23M11.49M11.79M11.21M11.61M11.14M11.63M10.66M11.42M8.46M7.87M8.71M9.50M9.07M8.00M5.42M8.58M13.72M13.28M
Current Assets (Quarter)
834.84M631.15M626.29M625.71M666.78M659.75M651.29M624.40M606.41M586.85M554.69M534.16M499.82M450.05M379.59M309.18M282.21M328.20M260.94M267.30M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
109.64M115.86M120.10M125.71M127.56M125.73M123.02M118.60M113.68M108.10M102.65M97.84M93.10M88.05M48.20M44.20M39.12M36.72M34.77M32.72M
Long-Term Investments (Quarter)
83.40M36.40M283.53M224.12M131.44M42.00M70.12M10.00M32.00M32.00M16.51M19.00M20.11M13.01M28.95M20.06M19.00M19.00M
Other Non-Current Assets (Quarter)
0.47M0.47M0.47M0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.29M0.29M0.29M1.69M1.69M1.58M1.58M1.58M1.59M
Non-Current Assets (Quarter)
395.03M567.19M501.12M446.40M354.90M317.52M286.27M256.05M228.94M208.13M195.34M160.06M154.32M169.17M111.27M120.62M103.24M79.76M79.11M83.32M
Assets (Quarter)
1,229.87M1,198.33M1,127.41M1,072.10M1,021.67M977.27M937.56M880.45M835.35M794.99M750.03M694.22M654.14M619.22M490.86M429.80M385.45M407.96M340.05M350.63M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
4.86M3.53M3.21M6.51M4.25M4.79M3.92M5.73M5.80M4.37M4.82M4.89M4.20M3.60M5.37M3.73M3.38M2.57M2.89M5.47M
Payables (Quarter)
4.86M3.53M3.21M6.51M4.25M4.79M3.92M5.73M5.80M4.37M4.82M4.89M4.20M3.60M5.37M3.73M3.38M2.57M2.89M5.47M
Accumulated Expenses (Quarter)
25.57M25.06M29.06M22.69M21.40M23.57M28.75M22.42M24.83M29.65M28.13M24.91M25.67M29.01M40.82M31.17M28.00M29.31M46.52M31.48M
Current Deferred Revenue (Quarter)
8.23M5.58M4.99M6.22M15.43M11.19M
Total Current Liabilities (Quarter)
63.66M59.28M46.74M41.05M50.29M51.22M37.03M30.80M34.39M35.06M34.52M32.35M30.88M33.51M53.79M41.28M36.90M31.88M49.41M36.95M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
81.88M81.88M79.67M77.87M32.93M37.16M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
61.50M65.68M66.65M67.47M67.55M67.47M63.17M66.64M60.22M58.58M56.89M55.16M60.22M51.44M50.99M48.85M55.11M44.28M41.92M48.85M
Other Non-Current Liabilities (Quarter)
0.90M5.01M4.57M4.45M4.34M4.23M4.11M4.00M3.89M3.78M3.66M3.55M3.44M3.56M3.25M3.14M3.03M2.68M0.52M0.53M
Total Non-Current Liabilities (Quarter)
207.01M206.85M193.05M186.40M149.29M153.02M100.20M92.62M94.61M93.64M91.41M87.51M84.20M84.95M104.78M90.14M83.50M76.16M91.33M76.43M
Total Liabilities (Quarter)
207.91M211.86M197.62M190.85M153.63M157.24M104.31M96.62M98.50M97.42M95.08M91.06M87.64M88.52M108.03M93.28M86.53M78.84M91.85M76.96M
Shareholder's Equity
Common Equity (Quarter)
1,021.96M986.47M929.79M881.25M868.04M820.03M833.25M783.83M736.86M697.57M654.95M603.16M566.50M530.70M382.82M336.52M298.92M329.12M248.20M273.67M
Shareholder's Equity (Quarter)
1,021.96M986.47M929.79M881.25M868.04M820.03M833.25M783.83M736.86M697.57M654.95M603.16M566.50M530.70M382.82M336.52M298.92M329.12M248.20M273.67M
Liabilities and Shareholders Equity (Quarter)
1,229.87M1,198.33M1,127.41M1,072.10M1,021.67M977.27M937.56M880.45M835.35M794.99M750.03M694.22M654.14M619.22M490.86M429.80M385.45M407.96M340.05M350.63M
Retained Earnings (Quarter)
-451.78M-0.07M-1.62M-652.51M-8.35M-10.00M-7.60M-3.88M-898.33M-1.18M-1002.11M-1062.78M-1108.59M0.76M0.29M-1397.30M-1439.98M0.20M0.24M-0.01M
Treasury Shares (Quarter)
4.55M3.58M2.60M1.63M1.25M0.99M0.87M2.61M2.62M2.78M2.07M2.70M5.17M4.43M0.28M2.70M0.38M0.08M0.31M0.53M
Shares Outstanding (Quarter)
238.55M239.79M242.74M245.42M247.11M249.24M12.48M249.61M251.03M251.87M12.70M12.75M12.80M12.83M14.74M14.76M14.83M19.29M21.25M23.33M